Sirolimus-eluting stent vs. everolimus-eluting stent for coronary intervention in patients on chronic hemodialysis

Circulation Journal

Volumn 76, Issue 2, 2012, Pages 351-355

  Sakakibara, Takashi ^a,b   Ishii, Hideki ^b   Toriyama, Takanobu ^a   Aoyama, Toru ^a   Takahashi, Hiroshi ^a   Kamoi, Daisuke ^a   Kawamura, Yoshihiro ^a   Kawashima, Kazuhiro ^a   Yoneda, Kohei ^a   Amano, Tetsuya ^b   Tanaka, Miho ^b   Yoshikawa, Daiji ^b   Hayashi, Mutsuharu ^b   Matsubara, Tatsuaki ^c   Murohara, Toyoaki ^b  

^a Nagoya Kyoritsu Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Drug eluting stent; Hemodialysis; Percutaneous coronary intervention; Restenosis

Indexed keywords

EVEROLIMUS; ISOSORBIDE DINITRATE; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMPARITIVE STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RIGHT CORONARY ARTERY; STABLE ANGINA PECTORIS; VASCULAR LESION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SIROLIMUS; TREATMENT OUTCOME;

EID: 84863011644     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0814     Document Type: Article

References (30)

1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Eng J Med 1998; 339: 799-805.
2. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al; The Hemodialysis (HEMO) Study. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
3. Kumada Y, Aoyama T, Ishii H, Tanaka M, Kawamura Y, Takahashi H, et al. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. Nephrol Dial Transplant 2008; 23: 3996-4001.
4. Ting HH, Tahirkheil NK, Berger PB, McCarthy JT, Timimi FK, Mathew V, et al. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol 2001; 87: 630-633.
5. Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006; 17: 2322-2332.
6. Hemmelgarn BR, Ghali WA, Quan H, Brant R, Norris CM, Taub KJ, et al. Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis 2001; 37: 64-72.
7. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 2006; 18: 577-583.
8. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents versus bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.
9. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008; 72: 1430-1435.
10. Nakazawa G, Tanabe K, Aoki J, Yamamoto H, Higashikuni Y, Onuma Y, et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-814.
11. Mori S, Yasuda S, Kataoka Y, Morii I, Kawamura A, Miyazaki S. Significant association of coronary artery calcification in stent delivery route with restenosis after sirolimus-eluting stent implantation. Circ J 2009; 73: 1856-1863.
12. Nakamura M, Yokoi H, Hamazaki Y, Watarai M, Kijima M, Mitsudo K; Cypher J-PMS Investigators. Impact of insulin-treated diabetes and hemodialysis on long-term clinical outcomes following sirolimuseluting stent deployment. Insights from a sub-study of the Cypher Stent Japan Post-Marketing Surveillance (Cypher J-PMS) Registry. Circ J 2010; 74: 2592-2597.
13. Otsuka Y, Ishikawa S, Inada T, Kanno H, Kyo E, Hayashi Y, et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: Insights from the Japan multi-centre post-marketing surveillance registry. Eur Heart J 2011; 32: 829-837.
14. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Akao M, Ono K, et al. Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization. Circ J 2011; 75: 1616-1625.
15. Räber L, Jüni P, Nüesch E, Kalesan B, Wenaweser P, Moschovitis A, et al. Long-term comparison of everolimus-eluting and sirolimuseluting stents for coronary revascularization. J Am Coll Cardiol 2011; 57: 2143-2151.
16. Smits PC, Kedhi E, Royaards KJ, Joesoef KS, Wassing J, Rademaker-Havinga TA, et al. 2-Year follow-up of a randomized controlled trial of everolimus-and paclitaxel-eluting stents for coronary revascularization in daily practice: The COMPARE (comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: A randomized open label trial) trial. J Am Coll Cardiol 2011; 58: 11-18.
17. Valenti R, Vergara R, Migliorini A, Parodi G, Buonamici P, Cerisano G, et al. Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions. Am J Cardiol 2011; 107: 1768-1771.
18. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trial. EuroIntervention 2006; 2: 286-294.
19. Onuma Y, Tanimoto S, Ruygrok P, Neuzner J, Piek JJ, Seth A, et al. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two-year angiographic and threeyear clinical results from the SPIRIT II study. Cathet Cardiovasc Interv 2010; 76: 634-642.
20. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB 3rd, McCallister BD, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American Heart Association/ American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutics Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987-3007.
21. Hase H, Nakamura M, Joki N, Tsunoda T, Nakamura R, Saijyo T, et al. Independent predictors of restenosis after percutaneous coronary revascularization in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 2372-2377.
22. Ishii H, Kumada Y, Toriyama T, Aoyama T, Takahashi H, Amano T, et al. Aortic valvular calcification predicts restenosis after implantation of drug-eluting stents in patients on chronic haemodialysis. Nephrol Dial Transplant 2009; 24: 1562-1567.
23. Ishii H, Toriyama T, Aoyama T, Takahashi H, Amano T, Hayashi M, et al. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Circ Cardiovasc Interv 2009; 2: 513-518.
24. Hao H, Ishibashi-Ueda H, Tsujimoto M, Ueda Y, Shite J, Gabbiani G, et al. Drug-eluting stent: Importance of clinico-pathological correlations. Circ J 2011; 75: 1548-1558.
25. Stone GW, Kedhi E, Kereiakes DJ, Parise H, Fahy M, Serruys PW, et al. Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus. Circulation 2011; 124: 893-900.
26. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 2006; 21: 1915-1920.
27. Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, Kolodgie FD, et al. Drug-eluting stent safety: Findings from preclinical studies. Expert Rev Cardiovasc Ther 2008; 6: 1379-1391.
28. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schühlen H, Neumann FJ, et al. Intracoronary stenting and angiographic results: Strut thickness effect on outcome (ISAR-STEREO) trial. Circulation 2001; 103: 2816-2821.
29. Schühlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, et al. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004; 147: 317-322.
30. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010; 304: 1350-1357.